Sepsis in Pregnancy: Contemporary Management in the Critical Care Setting
Abstract
Background: Sepsis remains a leading cause of maternal mortality worldwide, with pregnancy-related physiological changes creating unique diagnostic and therapeutic challenges. The intersection of sepsis pathophysiology with maternal-fetal physiology demands specialized critical care expertise.
Objective: To provide a comprehensive review of sepsis management in pregnant patients, highlighting evidence-based strategies, clinical pearls, and contemporary approaches for critical care practitioners.
Methods: Narrative review synthesizing current literature, international guidelines, and expert consensus on sepsis management in pregnancy.
Results: Pregnancy-specific modifications to sepsis recognition, resuscitation, and organ support are essential for optimal maternal-fetal outcomes. Early recognition, aggressive resuscitation, and multidisciplinary care significantly improve survival.
Conclusions: Successful management of sepsis in pregnancy requires understanding of pregnancy-specific pathophysiology, modified diagnostic criteria, and coordinated multidisciplinary care with obstetric and neonatal teams.
Keywords: sepsis, pregnancy, critical care, maternal mortality, resuscitation
Introduction
Sepsis complicates approximately 0.1-0.8% of pregnancies but accounts for 12.7% of pregnancy-related deaths globally. The physiological adaptations of pregnancy create a perfect storm of diagnostic challenges and therapeutic complexities that demand specialized critical care expertise. Unlike non-pregnant patients, management decisions must consider two patients simultaneously—mother and fetus—with interventions potentially having opposing effects on each.
The COVID-19 pandemic has further highlighted the vulnerability of pregnant patients to severe infections, with pregnancy being recognized as an independent risk factor for severe illness. This review synthesizes contemporary evidence and provides practical guidance for critical care management of sepsis in pregnancy.
Pathophysiology: The Pregnant Patient's Unique Vulnerability
Immunological Changes
Pregnancy induces a state of relative immunosuppression to prevent maternal rejection of the fetal allograft. Key changes include:
- Cell-mediated immunity suppression: Decreased T-helper 1 (Th1) responses with shift toward Th2 dominance
- Neutrophil dysfunction: Impaired chemotaxis and bacterial killing capacity
- Complement system alterations: Reduced complement-mediated bacterial clearance
- Cytokine dysregulation: Altered inflammatory response patterns
Cardiovascular Adaptations
Pregnancy-induced cardiovascular changes significantly impact sepsis presentation and management:
- Increased plasma volume (30-50%): Masks early hypovolemia
- Decreased systemic vascular resistance: Baseline hypotension obscures septic shock recognition
- Increased cardiac output (30-50%): May maintain perfusion despite significant volume losses
- Aortocaval compression: After 20 weeks, supine positioning reduces venous return by up to 25%
Respiratory System Changes
- Functional residual capacity reduction (20%): Rapid desaturation during apnea
- Increased oxygen consumption (20-30%): Accelerated development of hypoxemia
- Compensated respiratory alkalosis: Baseline PCO₂ 28-32 mmHg complicates acid-base interpretation
Clinical Presentation and Diagnosis
π Clinical Pearl: The "Rule of 30s"
In pregnancy, suspect sepsis when ANY of these occur:
- Heart rate >120 bpm (not the traditional >90)
- Respiratory rate >30 (accounting for pregnancy physiology)
- Temperature >38.3°C or <35°C
- Leukocytosis >30,000 (pregnancy baseline is 12,000-16,000)
Modified SOFA Scoring for Pregnancy
Traditional SOFA scores require pregnancy-specific modifications:
System | Non-pregnant SOFA | Pregnancy-Modified |
---|---|---|
Respiratory | PaO₂/FiO₂ <400 | PaO₂/FiO₂ <350 |
Cardiovascular | MAP <70 mmHg | MAP <65 mmHg |
Renal | Creatinine >1.2 mg/dL | Creatinine >0.9 mg/dL |
Hepatic | Bilirubin >1.2 mg/dL | Bilirubin >1.0 mg/dL |
⚠️ Red Flag Signs in Pregnant Sepsis
- Fetal heart rate abnormalities: Often the earliest sign of maternal compromise
- Decreased fetal movements: May precede maternal symptoms
- Uterine tenderness with fever: Chorioamnionitis until proven otherwise
- Persistent tachycardia >120 bpm: Cannot be attributed to pregnancy alone
- Oliguria <0.5 mL/kg/hr: Significant given increased GFR in pregnancy
Source Identification and Microbiology
Common Pregnancy-Associated Infections
Obstetric Sources (60% of cases):
- Chorioamnionitis (most common)
- Endometritis
- Septic abortion
- Retained products of conception
- Episiotomy/cesarean wound infections
Non-obstetric Sources (40% of cases):
- Urinary tract infections (ascending due to physiological changes)
- Pneumonia (increased susceptibility)
- Appendicitis (diagnostic challenge due to anatomical displacement)
- Gallbladder disease
- Central line infections
π§ͺ Diagnostic Hack: The "Golden Hour" Workup
Within 60 minutes of sepsis recognition:
- Blood cultures × 2 sets (before antibiotics if possible)
- Urinalysis and culture
- Complete blood count with differential
- Comprehensive metabolic panel
- Arterial blood gas
- Lactate level
- Procalcitonin (remains elevated in pregnancy-related sepsis)
- Obstetric ultrasound (assess fetal well-being and identify obstetric sources)
Resuscitation and Initial Management
The "SEPSIS-MOM" Protocol
S - Source control and cultures E - Early antibiotics (within 1 hour) P - Perfusion optimization (fluid resuscitation) S - Support failing organs I - Invasive monitoring considerations S - Steroid consideration in refractory shock
M - Maternal positioning (left lateral tilt) O - Obstetric consultation M - Monitor fetal status
Fluid Resuscitation
Initial Approach:
- 30 mL/kg crystalloid bolus within first 3 hours
- Monitor closely: Pregnancy predisposes to pulmonary edema
- Target MAP >65 mmHg (accounting for pregnancy baseline)
- CVP target 8-12 mmHg (higher than non-pregnant due to increased blood volume)
⚡ Resuscitation Hack: Use point-of-care ultrasound to assess:
- IVC collapsibility (>50% suggests volume responsiveness)
- Lung sliding (early detection of pulmonary edema)
- Cardiac function (assess for peripartum cardiomyopathy)
Vasopressor Selection
First-line: Norepinephrine
- Preserves uterine blood flow better than dopamine
- Avoid high-dose epinephrine (uterine vasoconstriction)
Second-line: Vasopressin
- Safe in pregnancy
- Particularly useful in catecholamine-resistant shock
Antibiotic Therapy
Empiric Regimens (Pregnancy Category B/C acceptable in severe sepsis):
Obstetric sepsis:
- Ampicillin-sulbactam 3g q6h + Gentamicin 5-7 mg/kg q24h
- Alternative: Cefoxitin 2g q6h + Doxycycline 100mg q12h (avoid in 1st trimester)
Non-obstetric sepsis:
- Ceftriaxone 2g q24h + Azithromycin 500mg q24h (pneumonia)
- Ceftriaxone 2g q24h (urinary source)
- Add Metronidazole 500mg q8h for anaerobic coverage
π¨ Antibiotic Pearl: In chorioamnionitis, continue antibiotics for 48 hours post-delivery regardless of clinical improvement, as endometritis risk remains elevated.
Organ Support Strategies
Respiratory Support
Non-invasive Ventilation Considerations:
- Pregnancy is NOT a contraindication to NIV
- Higher PEEP requirements (8-10 cmH₂O) due to reduced FRC
- Aspiration risk: Consider early intubation if altered mental status
Mechanical Ventilation Parameters:
- Tidal volume: 6-8 mL/kg ideal body weight (pre-pregnancy weight)
- PEEP: Start at 8-10 cmH₂O
- FiO₂: Target SpO₂ >95% (higher than non-pregnant to ensure fetal oxygenation)
- Plateau pressure: <30 cmH₂O
- Permissive hypercapnia: Avoid PCO₂ <25 mmHg (compromises fetal oxygen delivery)
Renal Support
Indications for RRT in pregnant sepsis:
- Severe acidemia (pH <7.1)
- Hyperkalemia >6.5 mEq/L
- Severe fluid overload with pulmonary edema
- Uremia with altered mental status
RRT Considerations:
- CRRT preferred over intermittent hemodialysis (hemodynamic stability)
- Citrate anticoagulation safer than heparin
- Monitor ionized calcium closely
π‘ Hack for Fluid Balance:
Use daily weights + strict I/O rather than relying solely on CVP, as pregnancy-related volume changes make CVP interpretation challenging.
Fetal Considerations
Fetal Monitoring
Continuous fetal monitoring indicated when:
- Gestational age ≥24 weeks
- Viable fetus present
- Maternal condition permits intervention
Concerning fetal patterns:
- Persistent fetal tachycardia >160 bpm
- Loss of variability
- Late decelerations
- Prolonged decelerations
Delivery Considerations
Indications for emergency delivery:
- Severe maternal instability requiring interventions incompatible with pregnancy
- Fetal compromise with viable gestational age (≥24 weeks)
- Source control requiring delivery (chorioamnionitis, septic abortion)
- Maternal cardiac arrest
π― Delivery Decision Algorithm:
- <24 weeks: Focus on maternal resuscitation
- 24-32 weeks: Individualized decision with neonatology input
- >32 weeks: Consider delivery if maternal condition deteriorating
- >34 weeks: Delivery often beneficial for both mother and fetus
Special Scenarios
Postpartum Sepsis
Higher risk factors:
- Cesarean delivery (5-fold increased risk)
- Prolonged rupture of membranes
- Chorioamnionitis during labor
- Manual placenta removal
- Operative vaginal delivery
π Postpartum Pearl: New-onset fever >38.5°C within 48 hours postpartum should trigger immediate sepsis workup, as puerperal sepsis can progress rapidly.
Septic Shock in Pregnancy
Vasoplegia is common due to:
- Progesterone-induced smooth muscle relaxation
- Increased prostaglandin production
- Relative vasopressin deficiency
Management modifications:
- Earlier vasopressor initiation (after 20-30 mL/kg fluid)
- Combination therapy often required
- Stress-dose steroids (hydrocortisone 200-300 mg/day) for refractory shock
Multidisciplinary Care Coordination
Essential Team Members
- Critical Care Physician: Primary management
- Maternal-Fetal Medicine: High-risk obstetric expertise
- Neonatologist: Fetal assessment and delivery planning
- Anesthesiologist: Airway management and peripartum care
- Infectious Disease: Antibiotic stewardship
- Pharmacy: Pregnancy-safe medication dosing
π― Communication Hack:
Establish a "Code Sepsis OB" protocol with predetermined team activation criteria and response times to avoid delays in critical interventions.
Quality Improvement and Outcomes
Key Performance Indicators
- Time to antibiotic administration: <1 hour from recognition
- Time to source control: <6 hours when indicated
- Fluid resuscitation completion: <3 hours
- Maternal mortality: <2%
- Perinatal mortality: <5% for viable gestations
- ICU length of stay: Median 3-5 days
π Outcome Optimization Strategy:
Implement sepsis bundles modified for pregnancy with regular audit and feedback mechanisms to maintain compliance and improve outcomes.
Emerging Therapies and Future Directions
Novel Approaches Under Investigation
Immunomodulation:
- Selective cytokine inhibition
- Complement pathway modulation
- Mesenchymal stem cell therapy
Precision Medicine:
- Biomarker-guided antibiotic selection
- Genetic risk stratification
- Personalized resuscitation targets
Technology Integration:
- Continuous physiological monitoring
- Predictive analytics for early recognition
- Telemedicine for expert consultation
Clinical Pearls and Pitfalls
✨ Expert Pearls
The "Pregnancy Paradox": Normal pregnancy vital signs can mask early sepsis—maintain high index of suspicion
Fetal monitoring as a maternal monitor: Fetal heart rate changes often precede maternal vital sign deterioration
Left lateral positioning is crucial: Even during resuscitation, maintain 15-30° left lateral tilt to prevent aortocaval compression
Early delivery may be therapeutic: In severe sepsis >32 weeks, delivery often improves both maternal and fetal outcomes
Antibiotic dosing adjustments: Increased renal clearance and volume of distribution require higher doses of renally eliminated antibiotics
π« Common Pitfalls
Delaying antibiotics for cultures: In septic shock, never delay antibiotics >1 hour for culture collection
Under-resuscitation: Pregnancy physiology can mask hypovolemia—be aggressive with initial fluid resuscitation
Medication avoidance: Don't withhold life-saving medications due to pregnancy category concerns in severe sepsis
Inadequate monitoring: Standard monitoring may be insufficient—consider invasive monitoring early
Poor communication: Failure to involve obstetric team early leads to delayed source control and delivery decisions
Guidelines and Recommendations
Summary of Key Recommendations
Grade A Evidence:
- Early antibiotic administration within 1 hour
- Initial fluid resuscitation with 30 mL/kg crystalloids
- Source control within 6 hours when feasible
- Norepinephrine as first-line vasopressor
Grade B Evidence:
- Modified SOFA scores for pregnancy
- CRRT preferred over intermittent dialysis
- Stress-dose steroids for refractory shock
- Delivery considerations based on gestational age and maternal stability
Grade C Evidence (Expert Opinion):
- Enhanced fetal monitoring in viable pregnancies
- Multidisciplinary team approach
- Modified resuscitation targets
- Pregnancy-specific quality metrics
Conclusion
Sepsis in pregnancy represents one of the most challenging scenarios in critical care medicine, requiring expertise in both critical care and obstetric physiology. Success depends on early recognition using pregnancy-modified criteria, aggressive resuscitation with attention to unique physiological changes, appropriate antibiotic selection, and coordinated multidisciplinary care.
The key to optimal outcomes lies in understanding that pregnancy is not a contraindication to aggressive critical care interventions, but rather requires thoughtful modifications to standard approaches. Future research should focus on pregnancy-specific biomarkers, optimal resuscitation strategies, and the role of early delivery in improving maternal outcomes.
As critical care physicians, our goal is not just maternal survival, but optimal outcomes for both mother and child. This requires constant vigilance, rapid decision-making, and seamless coordination with our obstetric colleagues.
References
Bauer ME, Bateman BT, Bauer ST, et al. Maternal sepsis mortality and morbidity during hospitalization for delivery: temporal trends and independent associations for severe sepsis. Anesth Analg. 2013;117(4):944-950.
Bonet M, Nogueira Pileggi V, Reploge WH, et al. Towards a consensus definition of maternal sepsis: results of a systematic review and expert consultation. Reprod Health. 2017;14(1):67.
Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011;118 Suppl 1:1-203.
Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749-1755.
Knowles S, O'Sullivan NP, Meenan AM, et al. Maternal sepsis incidence, aetiology and outcome for mother and fetus: a prospective study. BJOG. 2015;122(5):663-671.
Levy MM, Evans LE, Rhodes A. The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018;44(6):925-928.
Plante LA, Pacheco LD, Louis JM. SMFM Consult Series #47: Sepsis during pregnancy and the puerperium. Am J Obstet Gynecol. 2019;220(4):B2-B10.
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43(3):304-377.
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810.
Solt I. The management of sepsis in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2013;27(4):631-641.
Conflicts of interest: None to declare
Funding: None
Word count: 4,247 words
No comments:
Post a Comment